Three case reports of hand-foot syndrome with gefitinib.

Abstract:

:Hand-Foot Syndrome (HFS) is commonly reported in treatment with liposomal doxorubicin (LD) and capecitabine. We present 3 cases of HFS recall with gefitinib after previous LD therapy. The first 2 cases, in patients with head and neck cancer previously treated with paclitaxel and LD, developed on subsequent therapy with gefitinib. One patient had previously developed HFS on LD and the other had not. In both patients HFS resolved after stopping gefitinib. The third case is of a patient with ovarian cancer, also treated with gefitinib after LD, who developed HFS recall which resolved after gefitinib withdrawal. HFS can occur with gefitinib in patients who have been previously exposed to agents known to cause HFS.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Razis E,Karina M,Karanastassi S,Fountzilas G

doi

10.1080/07357900600814847

subject

Has Abstract

pub_date

2006-08-01 00:00:00

pages

514-6

issue

5

eissn

0735-7907

issn

1532-4192

pii

U787G38107752027

journal_volume

24

pub_type

杂志文章
  • A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience.

    abstract::PS-341, now known as bortezomib (Velcade[Millenium Pharmaceuticals, Inc., Cambridge, MA; and Johnson & Johnson Pharmaceutical Research & Development, LLC, Spring house, PA]), is a proteasome inhibitor approved for the treatment of refractory multiple myeloma. Preclinical and early clinical studies showed PS-341 to be ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701506573

    authors: Engel RH,Brown JA,Von Roenn JH,O'Regan RM,Bergan R,Badve S,Rademaker A,Gradishar WJ

    更新日期:2007-12-01 00:00:00

  • Cells of chemically induced tumors differentially express major histocompatibility complex class I antigens.

    abstract::Several recent studies have indicated that alterations in expression of major histocompatibility complex (MHC) antigens by tumor cells affects the ability of the host to mount an effective antitumor immune response. To investigate whether newly induced tumors frequently exhibit altered MHC antigen expression, we used ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909109021324

    authors: Reagan WJ,Pardi D,Callahan GN

    更新日期:1991-01-01 00:00:00

  • A 17 year-old man with an exon 11 mutation of CD-117 causing a gastrointestinal stromal tumor.

    abstract::Gastrointestinal stromal tumors (GIST) are tumors most frequently found in adults. They are often related to activating mutations in the CD-117 tyrosine kinase receptor, most commonly at exon 11. Gastrointestinal stromal tumors have been reported in children. However, until recently, there had not been reports of acti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701637824

    authors: Bauer TM,Berlin JD

    更新日期:2008-03-01 00:00:00

  • Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue.

    abstract::High-dose acetaminophen (HDAC) produces hepatocellular necrosis and cytotoxic changes in other tissues that express mixed-function-oxidase (MFO) activity. N-acetylcysteine (NAC), administered within 8 hr of HDAC exposure, replenishes reduced glutathione and prevents these effects. Numerous cell culture and animal stud...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909609012140

    authors: Kobrinsky NL,Hartfield D,Horner H,Maksymiuk A,Minuk GY,White DF,Feldstein TJ

    更新日期:1996-01-01 00:00:00

  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer.

    abstract::The efficacy of dose-intense methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy relative to conventional-dose M-VAC in patients with advanced transitional cell carcinoma is unknown. The outcomes of 33 patients on two successive protocols using dose-intense M-VAC with granulocyte colony-stimulat...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.3109/07357900009032829

    authors: Dodd PM,McCaffrey JA,Mazumdar M,Scher H,Higgins G,Boyle MG,Herr H,Bajorin DF

    更新日期:2000-01-01 00:00:00

  • Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?

    abstract::SNPs in CYP1A1, CYP2A1, CYP2B6, CYP2C, CYP2D6, CYP3A, GSTM1, GSTT1, GSTP1, SULT1A1, SULT1A2, UGT, and MTHFR are associated with breast cancer susceptibility; however, lack of such associations are also reported in some populations. The contradictory findings are explained on the basis of ethnic variation among populat...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900801953196

    authors: Singh V,Parmar D,Singh MP

    更新日期:2008-10-01 00:00:00

  • Molecular aspects of vitamin D anticancer activity.

    abstract::Environment may influence the development and prevention of cancer. Calcitriol has been associated with calcium homeostasis regulation. Many epidemiological, biochemical, and genetic studies have shown non-classic effects of vitamin D, such as its involvement in the progression of different cancers. Although vitamin D...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2012.721039

    authors: Picotto G,Liaudat AC,Bohl L,Tolosa de Talamoni N

    更新日期:2012-10-01 00:00:00

  • Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

    abstract::The WORLD07 study characterizes lung cancer in Spanish women. This analysis investigated lung cancer features in never-smoking women. Of 2072 women recruited, 2035 were analyzed. Patient characteristics and demographics were similar for current/former smokers and never smokers. Among never smokers, 38.3% were exposed ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.1080/07357907.2017.1295461

    authors: Viñolas N,Garrido P,Isla D,Provencio M,Majem M,Artal A,Carcereny E,Garcia Campelo R,Lianes P,De La Peñas R,Felip E

    更新日期:2017-05-28 00:00:00

  • UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.

    abstract::UFT is the combination of the fluorouracil (5-FU) prodrug tegafur, and the dihydrophyrimidine dehydrogenase inhibitor uracil. UFT and leucovorin have been used in the oral treatment of a variety of malignancies. Given the radiosensitizing properties of UFT, its combination with radiation therapy is a logical step in t...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120022382

    authors: Saad ED,Hoff PM

    更新日期:2003-01-01 00:00:00

  • Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.

    abstract::The transforming growth factor beta 1 (TGF-beta1) is a multifunctional cytokine with several regulatory activities in tumor cells affecting growth, differentiation, and function. Alterations in gene expression, secretion, and regulation of TGF-beta1 may lead to a favorable environment for tumor development by angiogen...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701600921

    authors: Faria PC,Saba K,Neves AF,Cordeiro ER,Marangoni K,Freitas DG,Goulart LR

    更新日期:2007-12-01 00:00:00

  • Phase I-II trial of high-dose melphalan in previously untreated stage III multiple myeloma: Cancer and Leukemia Group B study 8512.

    abstract::To study the efficiency of high-dose melphalan in previously untreated patients with advanced myeloma, we performed a Phase I-II trial. Twenty-eight patients were treated at dose level of 60-140 mg/m2. Each patient was first treated with a priming dose of cyclophosphamide (300 mg) followed by high-dose melphalen 1 wee...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909209032784

    authors: Case DC Jr,Coleman M,Gottlieb A,McCarroll K

    更新日期:1992-01-01 00:00:00

  • ZBTB7 overexpression contributes to malignancy in breast cancer.

    abstract::ZBTB7 was recently recognized as a proto-oncogene. We studied its prognostic value and relationship to clinicopathological variables in 125 breast cancer patients. ZBTB7 expression was significantly higher in breast cancer tissues than in normal breast tissues, but its gene amplification copies were relatively low. ZB...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003631007

    authors: Qu H,Qu D,Chen F,Zhang Z,Liu B,Liu H

    更新日期:2010-07-01 00:00:00

  • Signal transduction pathways involved in the lineage-differentiation of NSCs: can the knowledge gained from blood be used in the brain?

    abstract::Neural stem cells (NSC) are capable of differentiating toward neuronal, astrocytic, oligodendrocytic and glial lineages, depending on their spatial location within the central nervous system (CNS). Although, a lot of knowledge has been gained in the understanding of differentiation-specific signaling in hematopoietic ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200039679

    authors: Mondal D,Pradhan L,LaRussa VF

    更新日期:2004-01-01 00:00:00

  • The response of the microvascular system to radiation: a review.

    abstract::The microvasculature is a ubiquitous organ system having a major role in the pathogenesis of radiation damage to normal tissues. Although the kinetics of radiation damage to endothelial cells is similar to other tissues (as reflected by Do and Dq) the late effect is a manifestation of injury, not only to the endotheli...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908909039849

    authors: Baker DG,Krochak RJ

    更新日期:1989-01-01 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • Synthetic, non-natural analogs of ceramide elevate cellular ceramide, inducing apoptotic death to prostate cancer cells and eradicating tumors in mice.

    abstract::The anticancer effects of synthetic, non-natural analogs of ceramide were tested using human TSU-Pr1 prostate cancer cells in-vitro as well as in-vivo, following their effects on tumors development in mice. When incubated with the cultured cancer cells, the analogs elevated cellular ceramide and induced a cytotoxicity...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903478915

    authors: Qin JD,Weiss L,Slavin S,Gatt S,Dagan A

    更新日期:2010-06-01 00:00:00

  • MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer.

    abstract::In this study, we investigated ALDH1A3, Mcl1, and miR-125a/b expression in HT29 cells and the effect of miR-125a/b on ALDH1A3 and Mcl1 expression. Our results showed that low expression of miR-125a/b and high expression of ALDH1A3 and Mel1 were observed in both ALDH1-positive HT29 and HT29-taxol cells. Overexpression ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.743557

    authors: Chen J,Chen Y,Chen Z

    更新日期:2013-01-01 00:00:00

  • Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer.

    abstract::Between March 1986 and December 1987, two groups of consecutive patients with advanced breast cancer underwent epidoxorubicin (Epidx) monochemotherapy. Twenty-three patients (group A) received Epidx at a dose of 60 mg/m2 and 27 (group B) at a dose of 120 mg/m2 (i.v. every 3 weeks). No patient had undergone anthracycli...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909309024827

    authors: Neri B,Pacini P,Algeri R,Lottini G,Rinaldini M,Tucci E,Pusterla R

    更新日期:1993-01-01 00:00:00

  • Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.

    abstract::The purpose of this study was to assess the usefulness of thallium-201 (Tl-201) single-photon emission-computed tomography (SPECT) scintimammography to differentiate benign from malignant breast masses in 32 female Taiwanese patients with indeterminate mammographic probability of malignancy because of mammographically...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120025089

    authors: Chiou JF,Lin MC,Chen DR,Jim YF,Kao CH

    更新日期:2003-01-01 00:00:00

  • Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects.

    abstract::Tamoxifen is a first targeted drug that continues to be the gold standard in treatment of estrogen receptor positive breast cancer for almost 50 years. The current review is an update of the paper published in 2012. We provide the new data on the tamoxifen targets that are the key points of signaling cascades activati...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2018.1453933

    authors: Bogush TA,Polezhaev BB,Mamichev IA,Bogush EA,Polotsky BE,Tjulandin SA,Ryabov AB

    更新日期:2018-04-21 00:00:00

  • The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth.

    abstract::Tissues become more rigid during tumorigenesis and have been identified as a driving factor for tumor growth. Here, we highlight the concept of tissue rigidity, contributing factors that increase tissue rigidity, and mechanisms that promote tumor growth initiated by increased tissue rigidity. Various factors lead to i...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2020.1802474

    authors: Zakaria MA,Rajab NF,Chua EW,Selvarajah GT,Masre SF

    更新日期:2020-09-01 00:00:00

  • Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer.

    abstract:BACKGROUND:Although treatment-related lymphopenia (TRL) is common in many cancers no data exists in rectal cancer. METHODS:Serial lymphocyte counts were analyzed retrospectively in patients with newly diagnosed rectal cancer, serial blood counts, and complete records at Johns Hopkins Hospital. RESULTS:Fifty-seven pat...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1499028

    authors: Campian JL,Ye X,Sarai G,Herman J,Grossman SA

    更新日期:2018-01-01 00:00:00

  • Immune senescence: mechanisms and clinical implications.

    abstract::There are many changes in the immune response with age, most of which can be related to the involution of the thymus gland and alteration of the distribution and function of T lymphocytes. These changes indirectly influence B-cell function, which not only amplifies the immune deficits, but leads to the increased produ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909209024815

    authors: Ben-Yehuda A,Weksler ME

    更新日期:1992-01-01 00:00:00

  • Non-Viral Parasites Associated with Carcinogenesis.

    abstract::Cancer is a proficient evader of the immune system and is responsible for a high number of deaths annually. Most of these cancer cases are associated with genetic mutations, viruses, radiations or other carcinogenic substances like tobacco smoke. However, a significant number of cases arise as a result of infection by...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2019.1662918

    authors: Jain S,Sengupta M,Jain P

    更新日期:2019-01-01 00:00:00

  • Polymorphic AAAG repeat length in estrogen-related receptor gamma (ERRγ) and risk of breast cancer in Iranian women.

    abstract::Estrogen-related receptors (ERRs) alpha, beta, and gamma are orphan nuclear receptors that modulate the estrogen signaling pathway and play roles in the regulation of breast cancer cell growth. To determine the association between breast cancer risk and alleles of the tetranucleotide repeat (AAAG)n in the intron of ER...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.845672

    authors: Karimi P,Hematti S,Safari F,Tavassoli M

    更新日期:2013-11-01 00:00:00

  • Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.

    abstract::Mice bearing LP07 lung adenocarcinoma present some characteristics similar to those shown in patients with several malignant diseases. LP07 tumor bearers develop paraneoplastic syndromes such as cachexia, leukocytosis, and hypercalcemia, partly due to a systemic inflammatory response. We analyzed some of the mechanism...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900500524322

    authors: Diament MJ,Peluffo GD,Stillitani I,Cerchietti LC,Navigante A,Ranuncolo SM,Klein SM

    更新日期:2006-03-01 00:00:00

  • Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.

    abstract::A case control study was undertaken to investigate the association of polymorphisms in cytochrome P4501A1 (CYP1A1) with squamous cell carcinoma of head and neck (HNSCC) in North Indian population. The variant genotypes of CYP1A1*2A and CYP1A1*2C were found to be overrepresented in cases when compared to controls. The ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900902849657

    authors: Singh AP,Shah PP,Ruwali M,Mathur N,Pant MC,Parmar D

    更新日期:2009-10-01 00:00:00

  • Apoptosis in lymphocytic leukemias and lymphomas.

    abstract::Most current classifications of lymphoid neoplasms define the tumors based on the cell of origin, phenotype, genetic abnormalities, and clinical features. Here it is proposed that human lymphocytic tumors can be categorized based on the propensity and capacity of the tumor cells to undergo apoptosis. The first categor...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120002951

    authors: Schattner EJ

    更新日期:2002-01-01 00:00:00

  • Antiproliferative and survival properties of PMA in MCF-7 breast cancer cell.

    abstract::Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, such as chimaerins (a family of RacGTPase activating proteins) and RasGRP (exchange factor for Ras/Rap1), can counteract or strengthen the PKC pathways. In this study, we evaluated the proliferative behavior of PMA-trea...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701637949

    authors: Fortino V,Torricelli C,Capurro E,Sacchi G,Valacchi G,Maioli E

    更新日期:2008-02-01 00:00:00

  • Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma.

    abstract::Melanoma is an immunoresponsive malignancy. Interleukin-10 (IL-10) is a potent regulator of immunosuppression. The purpose of this research was to define the relationship of serum IL-10 to survival in patients with metastatic melanoma. Forty-one melanoma patients and 50 normal volunteers were analyzed. The median IL-1...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100102550

    authors: Nemunaitis J,Fong T,Shabe P,Martineau D,Ando D

    更新日期:2001-01-01 00:00:00